1.
Walter RB, Medeiros BC, Powell BL, Schiffer CA, Appelbaum FR, Estey EH. Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia. Haematologica [Internet]. 2012May3 [cited 2026Nov.10];97(5):739-42. Available from: https://haematologica.org/article/view/6300